BRAF and leukemia: The available leukemia cell lines JVM3 (K601N BRAF) and SIG-M5 (V600E BRAF) were used for comparison of these two mutations since no pancreatic neuroendocrine cell lines exist that express these mutations (and attempts to culture the patient’s cancer cells were unsuccessful).